BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17/09/2004

FDA Clears ZOLOFT Tablets for Approval of Generic Sertraline HCl

The FDA has determined that ZOLOFT tablets, 150mg and 200mg, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of generic sertraline HCl tablets.

Source: Federal Register — Food and Drug AdministrationOpen original release →